IL6 and bacterial infectious disease with sepsis: A recent elegant study has identified unique immune signatures in severe COVID-19 patients, characterized by a high sustained cytokine production of interleukin-6 (IL-6), a pleiotropic cytokine with multiple effects in these patients, distinct from patients with bacterial sepsis.